Helix Nanotechnologies

Helix Nanotechnologies is pioneering a next-generation mRNA platform with the potential to revolutionize treatments for critical global challenges, including cancer, COVID-19, and climate change. Just as technology enables the rapid retrieval of information and delivery of physical goods, mRNA offers a similar capability for biological systems. HelixNano envisions a future where medical treatments are affordable and accessible, scientific progress is decentralized, and biological modifications can be achieved with ease.

By fundamentally improving mRNA technology, HelixNano is accelerating the pace of discovery. Experiments that once took months or years can now be completed in weeks, with significantly reduced costs. The primary constraint on progress is now scientific curiosity and exploration.

HelixNano fosters an environment that values innovation from all levels of the organization. Recognizing that groundbreaking discoveries often emerge from unexpected sources, the company empowers individual scientists to influence its direction. A diverse team is considered essential for identifying and developing truly transformative ideas.

The company has already begun deploying its novel technologies, including advancing a COVID-19 vaccine candidate for immunocompromised individuals towards clinical trials and testing an intervention with substantial environmental benefits. With a strong scientific foundation, HelixNano remains focused on expanding the horizons of mRNA technology.